WIDAD ALAMI: Open Payments
NPI 1871106906 · WAYNESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 18 payments from 7 companies in 2025. Trend: 2023 $93 · 2024 $314 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $126 |
| Collegium Pharmaceutical, Inc. | 4 | $84 |
| Forte Bio-Pharma LLC | 3 | $60 |
| Valinor Pharma, LLC | 2 | $42 |
| IBSA Pharma Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
Products named: UBRELVY, Belbuca, PROLATE, MOVANTIK, QULIPTA, Tirosint, HORIZANT, ETERNA.
Industry payments across NC — which companies pay providers there.
